Vernalis plc is a commercial-stage pharmaceutical company. The Company is engaged in the research, development and commercialization of pharmaceutical products. The Company operates through two segments: Commercial, which covers all areas relating to the commercial sale of pharmaceutical products, the manufacture and distribution directly related to that activity, and Research and Development, which includes all activities related to the research and development of pharmaceutical products for a range of medical disorders. The Company markets three products, including Tuzistra XR in the United States prescription cough cold market; Moxatag, which is a once daily amoxicillin approved in the United States for tonsillitis and pharyngitis, and frovatriptan, which is an acute treatment for migraine. The Company also has four over prescription cough cold products under development and a pipeline of new chemical entity (NCE) development programs and research collaborations.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:VER
- CUSIP: N/A
- Web: N/A
- Market Cap: £95.4 million
- Outstanding Shares: 526,351,000
- 50 Day Moving Avg: GBX 20.99
- 200 Day Moving Avg: GBX 28.59
- 52 Week Range: GBX 16 - GBX 49.75
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £11.87 million
- Price / Sales: 8.04
- Book Value: GBX 0.18 per share
- Price / Book: 1.03
- Average Volume: 452,628 shs.
Frequently Asked Questions for Vernalis plc (LON:VER)
What is Vernalis plc's stock symbol?
Vernalis plc trades on the London Stock Exchange (LON) under the ticker symbol "VER."
Where is Vernalis plc's stock going? Where will Vernalis plc's stock price be in 2017?
5 brokers have issued 12 month price objectives for Vernalis plc's stock. Their predictions range from GBX 24 to GBX 88. On average, they anticipate Vernalis plc's share price to reach GBX 46.80 in the next year. View Analyst Ratings for Vernalis plc.
Who are some of Vernalis plc's key competitors?
Some companies that are related to Vernalis plc include Microgen plc (MCGN), Tiziana Life Sciences PLC (TILS), Vertu Motors Plc (VTU), Tribal Group plc (TRB), Quartix Holdings PLC (QTX), Shield Therapeutics PLC (STX), Topps Tiles Plc (TPT), Cohort PLC (CHRT), Gateley Holdings PLC (GTLY), Findel plc (FDL), Charles Stanley Group plc (CAY), Somero Enterprises (SOM), Rhythmone PLC (RTHM), Morses Club PLC (MCL), Acal plc (ACL), CityFibre Infrastructure Holdings PLC (CITY), Epwin Group PLC (EPWN) and James Latham plc (LTHM).
How do I buy Vernalis plc stock?
Shares of Vernalis plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Vernalis plc stock cost?
One share of Vernalis plc stock can currently be purchased for approximately GBX 18.13.
Earnings History for Vernalis plc (LON:VER)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Vernalis plc (LON:VER)
Current Year EPS Consensus Estimate: $-5.570 EPS
Dividend History for Vernalis plc (LON:VER)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Vernalis plc (LON:VER)Insider Trades by Quarter for Vernalis plc (LON:VER)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/12/2016||David Mackney||Insider||Sell||27,233||GBX 39||£10,620.87|
|9/30/2016||Carol Ferguson||Insider||Buy||28,000||GBX 41||£11,480|
|5/5/2015||Nigel Sheail||Insider||Buy||84,000||GBX 59.90||£50,316|
Headline Trends for Vernalis plc (LON:VER)
Latest Headlines for Vernalis plc (LON:VER)
Vernalis plc (VER) Chart for Thursday, May, 25, 2017